Stage-Dependent Levels of Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase 9 in the Prognosis of Colorectal Cancer
Overview
Authors
Affiliations
Purpose: The development of sensitive and non-invasive biomarkers for the early detection of CRC and determination of their role in the individual stages of CRC.
Methods: MMP-9 expression in serum and tissue, and BDNF expression in plasma were detected using the ELISA method. MMP-9 and BDNF in the tissue were also determined by immunohistochemical staining.
Results: To assess the balance between changes in survival and tumor progression, we compared BDNF/MMP-9 ratios in tissues of living and deceased individuals. The tissue BDNF/MMP-9 ratio (evaluated immunohistochemically) decreased significantly with the progression of the disease in living patients. The BDNF/MMP-9 ratio was statistically significantly reduced in stages II and III compared to the benign group. However, in deceased individuals, the ratio showed an opposite tendency.
Conclusion: The determination of the tissue BDNF/MMP9 ratio can be used as a prognostic biomarker of CRC.
Xia J, Zhuo W, Deng L, Yin S, Tang S, Yi L Oncol Lett. 2025; 29(4):191.
PMID: 40041412 PMC: 11877015. DOI: 10.3892/ol.2025.14937.
Zhang T, Si H, Liao J, Ma R Sci Rep. 2024; 14(1):30911.
PMID: 39730669 PMC: 11680849. DOI: 10.1038/s41598-024-81895-w.